InVivoMab anti-mouse CD73 BE0209-R001mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse CD73
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0209-R001mg
Quantity1 mg
Applicationsin vivo CD73 blockade, in vitro CD73 blockade
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetCD73
IsotypeIgG2a, κ
CloneTY/23
Hostrat
NCBI Full Gene Name5' nucleotidase, ecto
NCBI Gene Aliases2210401F01Rik, 5'-NT, CD73, NT, Nt5, eNT
ClonalityMonoclonal
ImmunogenBALB/c mouse spleen cells and CHO cells transfected with the mouse CD73 gene
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immunology

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

(1) Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8⁺ T Cell ResponsesImmunityMarch 19, 2019Zhang F, Li R, Yang Y, Shi C, Shen Y, Lu C, Chen Y, Zhou W, Lin A, Yu L, et al.

(2) Anti-CD73 therapy impairs tumor angiogenesisInternational journal of cancerMarch 15, 2014Allard B, Turcotte M, Spring K, Pommey S, Royal I, Stagg J.

(3) Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbsClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 15, 2013Allard B, Pommey S, Smyth MJ, Stagg J.

InVivoMab anti-mouse CD73